Literature DB >> 6282299

Interaction of radiosensitizers and WR-2721. I. Modification of skin radioprotection.

A Rojas, F A Stewart, J Denekamp.   

Abstract

We have studied the radiomodifying action in mouse skin of WR-2721 and misonidazole (MISO) when used alone or in combination. The radioprotection with WR-2721 was drug-dose dependent and highly influenced by the O2 concentration at the time of irradiation. Significant sensitizaton was observed with MISO, especially in air-breathing mice. The combination of WR-2721 and MISO produced a radiation response intermediate between the resistant and sensitive responses to either drug alone. The precise degree of sensitivity was dependent on the relative doses of protector and sensitizer. We have also studied the interaction of both drugs in terms of drug-induced lethality, which showed a clear toxic interaction. The WR-2721 LD50 was reduced by a factor of 1.4 with only 200 mg/kg of MISO. We conclude that the combination of WR-2721 and MISO shows an interaction in terms of drug toxicity and radiation response, such that the radioprotection of skin is reduced or even abolished with low doses of MISO.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6282299      PMCID: PMC2011016          DOI: 10.1038/bjc.1982.109

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  31 in total

1.  Role of oxygen in modifying the radiosensitivity of E. coli B.

Authors:  T ALPER; P HOWARD-FLANDERS
Journal:  Nature       Date:  1956-11-03       Impact factor: 49.962

2.  Misonidazole-a drug for trial in radiotherapy and oncology.

Authors:  S Dische; M I Saunders; I R Flockhart; M E Lee; P Anderson
Journal:  Int J Radiat Oncol Biol Phys       Date:  1979-06       Impact factor: 7.038

3.  Combined use of radioprotective and radiosensitizing drugs in experimental radiotherapy.

Authors:  J M Yuhas; M Yurconic; M M Kligerman; G West; D F Peterson
Journal:  Radiat Res       Date:  1977-05       Impact factor: 2.841

4.  Reducing compounds in radioprotection and radiosensitization: model experiments using ascorbic acid.

Authors:  J L Redpath; R L Willson
Journal:  Int J Radiat Biol Relat Stud Phys Chem Med       Date:  1973-01

5.  Differential chemoprotection of normal and malignant tissues.

Authors:  J M Yuhas; J B Storer
Journal:  J Natl Cancer Inst       Date:  1969-02       Impact factor: 13.506

6.  Radiobiolgoical and biochemical studies of thiophosphate radioprotective compounds related to cysteamine.

Authors:  J W Harris; T L Phillips
Journal:  Radiat Res       Date:  1971-05       Impact factor: 2.841

7.  Thiol radioprotection in vivo: the critical role of tissue oxygen concentration.

Authors:  J Denekamp; B D Michael; A Rojas; F A Stewart
Journal:  Br J Radiol       Date:  1981-12       Impact factor: 3.039

8.  A cautionary note on the use of thiol compounds to protect normal tissues in radiotherapy.

Authors:  J Lunec; B Cullen; H Walker; S Hornsey
Journal:  Br J Radiol       Date:  1981-05       Impact factor: 3.039

9.  Correlation between the radiobiological oxygen constant, K, and the non-protein sulphydryl content of mammalian cells.

Authors:  B M Cullen; A Michalowski; H C Walker; L Révész
Journal:  Int J Radiat Biol Relat Stud Phys Chem Med       Date:  1980-11

10.  Modification of the oral radiation death syndrome with combined WR-2721 and misonidazole.

Authors:  P Grigsby; Y Maruyama
Journal:  Br J Radiol       Date:  1981-11       Impact factor: 3.039

View more
  4 in total

Review 1.  Modifiers of radiosensitivity.

Authors:  A Rojas; J Denekamp
Journal:  Experientia       Date:  1989-01-15

Review 2.  Amifostine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential as a radioprotector and cytotoxic chemoprotector.

Authors:  C M Spencer; K L Goa
Journal:  Drugs       Date:  1995-12       Impact factor: 9.546

3.  The effect of misonidazole combined with WR2721 on tumour response and leucopenia due to cyclophosphamide or melphalan.

Authors:  N J McNally
Journal:  Br J Cancer       Date:  1982-10       Impact factor: 7.640

4.  Interaction of misonidazole and WR-2721--II. Modification of tumour radiosensitization.

Authors:  A Rojas; F A Stewart; J Denekamp
Journal:  Br J Cancer       Date:  1983-01       Impact factor: 7.640

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.